Elimination of clonogenic breast cancer cells from human bone marrow. A comparison of immunotoxin treatment with chemoimmunoseparation using 4-hydroperoxycyclophosphamide, monoclonal antibodies, and magnetic microspheres
- 15 September 1991
- Vol. 68 (6) , 1272-1278
- https://doi.org/10.1002/1097-0142(19910915)68:6<1272::aid-cncr2820680616>3.0.co;2-l
Abstract
Autologous bone marrow transplantation (ABMT) may aid in the management of breast cancer, but is currently limited to patients without bone marrow metastases. In earlier studies, 5 logs of malignant clonogenic breast cancer cells could be eliminated from human bone marrow using a combination of chemoseparation with 4‐hydroperoxycyclophosphamide (4‐HC) and immunoseparation with monoclonal antibodies and magnetic microspheres. In this report the authors compare chemoimmunoseparation to treatment with immunotoxins for elimination of tumor cells from human bone marrow and for the preservation of normal precursors. Breast cancer cells from each of five cell lines were mixed with a tenfold excess of irradiated human bone marrow cells. Treatment with a combination of five immunotoxins reduced clonogenic tumor cell growth by 1.8 to 5.5 logs depending upon the cell line. With two of the five cell lines, clonogenic tumor cells were eliminated quantitatively. Using the CAMA‐1 breast cancer cell line, treatment with multiple immunotoxins was compared with chemoimmunoseparation with 4‐HC, a panel of five unconjugated monoclonal antibodies and magnetic microspheres. Chemoimmunoseparation eliminated 3.5 to 5.4 logs of malignant cells, while preserving 21% of Colony‐forming unit‐granulocyte‐macrophage (CFU‐GM) and 37% of burst‐forming unit‐erythrocyte (BFU‐E). No clonogenic breast cancer cells could be detected. Immunotoxin treatment eliminated 2.2 to 5.4 logs of clonogenic breast cancer cells, but had no effect on the bone marrow precursors. In seven of ten experiments, however, clonogenic breast cancer cells remained after immunotoxin treatment. Consequently, treatment with 4‐HC, multiple murine monoclonal antibodies and magnetic microspheres provided more consistent elimination of tumor cells than separation with immunotoxins, but was significantly more toxic for marrow precursors.Keywords
This publication has 19 references indexed in Scilit:
- The duke afm program intensive induction chemotherapy for metastatic breast cancerCancer, 1990
- Heterogeneity of antigen expression in benign and malignant breast and ovarian epithelial cellsInternational Journal of Cancer, 1989
- High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer.Journal of Clinical Oncology, 1988
- Low Antigen Density Tumor Cells: An Obstacle to Effective Autologous Bone Marrow Purging?Cancer Investigation, 1987
- Marrow purging in autologous bone marrow transplantation for T-lineage acute lymphoblastic leukemia: efficacy of ex vivo treatment with immunotoxins and 4-hydroperoxycyclophosphamide against fresh leukemic marrow progenitor cellsBlood, 1987
- Elimination of clonogenic Burkitt's lymphoma cells from human bone marrow using 4-hydroperoxycyclophosphamide in combination with monoclonal antibodies and complementBlood, 1985
- EX-VIVO TREATMENT OF DONOR BONE MARROW WITH ANTI-T-CELL IMMUNOTOXINS FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASEThe Lancet, 1984
- Absence of HeLa Cell Contamination in 169 Cell Lines Derived From Human Tumors2JNCI Journal of the National Cancer Institute, 1977
- Human Tumor Cells in VitroPublished by Springer Nature ,1975
- A Human Cell Line From a Pleural Effusion Derived From a Breast Carcinoma 2JNCI Journal of the National Cancer Institute, 1973